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ABSTRACT 
 
 mRNA export from the nucleus depends on the ATPase activity of the DEAD-box 
protein Dbp5/DDX19. Although Dbp5 has measurable ATPase activity alone, several regulatory 
factors (e.g. RNA, nucleoporin proteins, and the endogenous small molecule InsP6) modulate 
catalytic activity in vitro and in vivo to facilitate mRNA export. To define how these factors 
control Dbp5 and mRNA export, an analysis of the intrinsic and regulator-activated Dbp5 
ATPase cycle is necessary. Here, we report a kinetic and equilibrium analysis of the 
Saccharomyces cerevisiae Dbp5 ATPase cycle, including the influence of RNA on Dbp5 
activity. These data show that ATP binds Dbp5 weakly in rapid equilibrium with a binding 
affinity (KT ~ 4 mM) comparable to the KM for steady-state cycling, while ADP binds an order of 
magnitude more tightly (KD ~ 0.4 mM). The overall intrinsic steady-state cycling rate constant 
(kcat) is limited by slow, near-irreversible ATP hydrolysis and even slower subsequent phosphate 
release. RNA increases kcat and rate-limiting Pi release 20-fold, although Pi release continues to 
limit steady-state cycling in the presence of RNA, in conjunction with RNA binding. Together 
this work identifies RNA binding and Pi release as important biochemical transitions within the 
Dbp5 ATPase cycle and provides a framework for investigating the means by which Dbp5 and 
mRNA export is modulated by regulatory factors.   
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INTRODUCTION 
DEAD-box proteins (DBPs) are ATPase enzymes central to RNA metabolism in all domains of 
life.
1-3
 Many DBPs function as bona fide helicases that unwind duplex RNA, while others are 
involved in RNA-protein complex remodeling,
4-6
 RNA folding,
7, 8
 or serve as RNA sensors 
within the cell.
9, 10
 DBPs accomplish this enormous diversity in function using a highly 
conserved catalytic core that couples ATP hydrolysis to nucleic acid binding and release.
3, 8, 11, 12
 
Consequently, DBPs are presumed to perform work via a common minimal enzymatic scheme 
involving ATP binding, hydrolysis, and subsequent phosphate (Pi) and ADP product release.
8, 11, 
13, 14
   
The functional diversity of DBPs is thought to stem in part from kinetic and 
thermodynamic adaptations of this common ATPase cycling scheme.
8
 For example, DbpA and 
Mss116 share a common RNA-activated ATPase cycle pathway, but variations in the catalytic 
cycle rate and equilibrium constants uniquely alter their interaction with RNA, which may allow 
them to fulfill specific biological functions.
8, 13-15
 This adaptive behavior is analogous to the duty 
ratios of cytoskeleton motor proteins and demonstrates how kinetic modulation broadens the 
biological activities of an enzyme family.
8, 16
   
The inherent TPase cycles of some DBPs are additionally regulated through ancillary 
domains that mediate interactions with regulatory factors that can include RNAs and/or proteins. 
For example, Dbp5 is a DBP required for nuclear mRNA export that is stimulated by RNA and 
further regulated by two nucleoporin proteins (Gle1 and Nup159) and an endogenous small 
molecule (inositol hexakisphosphate or InsP6).
17-28
 While it is clear that all components have 
global in vitro and in vivo effects on Dbp5 activity, there is not yet a consensus on the individual 
and concerted effects of these factors at a mechanistic level. Critical to deciphering the effect of 
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regulators on the ATPase cycle of Dbp5, or any DBP, is a quantitative characterization of the 
intrinsic ATPase cycle, as it is only with this base knowledge that we can undertake future in-
depth studies on the mechanism of regulation by trans-activating factors and apply this to 
understanding the in vivo cellular function of DBPs. Deducing how trans-activating factors 
modulate the ATPase cycle of individual DBPs and the functions that emerge from this 
regulation will also further our understanding of this important class of enzymes as a whole, 
which function in almost all aspects of RNA biology.   
Here, we have determined the minimal ATPase cycle and calculated the rate and 
equilibrium constants of individual biochemical transitions for Dbp5. This work has identified 
slow ATP hydrolysis and even slower subsequent phosphate release as key bottlenecks in the 
ATPase cycle of Dbp5 that function as targets for modulation by RNA and other regulatory 
cofactors. We also show that the fluorescent nucleotides N-methylanthraniloyl ATP and ADP 
(mantATP, mantADP), common tools for kinetic studies of ATPases,
29-33
 significantly alter the 
ATPase cycle rate and equilibrium constants of Dbp5 (Supplementary Information). Although 
mant-labeled nucleotides have been found to alter the catalytic cycles of other molecular motors, 
this is the first example to our knowledge of such significant mant fluorophore-induced 
alterations in DBP behavior, and highlights the ongoing need for system-specific controls 
regarding fluorescent labels.
33-36
  
Having defined the minimal catalytic ATPase cycle of Dbp5, we show that in the 
presence of RNA phosphate release remains a limiting step in the hydrolysis cycle of Dbp5. 
However, we also observe evidence of a new RNA binding-associated rate-limiting step in the 
kinetic scheme of Dbp5, which identifies an additional feature in the minimal kinetic scheme of 
RNA-stimulated ATPase activity. Overall, by understanding the steps that limit Dbp5 function in 
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 6 
various biochemical states (e.g. RNA-bound vs. free) we are building a framework for 
understanding Dbp5 function in vivo, which may vary for the sub-cellular pools of Dbp5 and 
depend upon different regulators given the various functions proposed for these populations of 
Dbp5.
17-20, 37-42
   
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 7 
RESULTS 
A. Intrinsic ATPase activity of Dbp5 
Steady state ATPase measurements 
Dbp5 has intrinsic ATPase activity in the absence of RNA or other regulatory factors.
18, 
20, 22
 As an essential starting point for quantitative analysis of the ATPase cycle of Dbp5, we first 
determined the maximal per-enzyme cycling rate, or kcat (in units of s
-1
). Under our experimental 
conditions using both the NADH-coupled assay to detect ADP product formation and PiBiP to 
detect phosphate product accumulation,
43, 44
 kcat is 0.04-0.08 s
-1
 in the presence of saturating ATP 
(Fig. 1, Table 1). The KM for ATP substrate (KM,ATP) is 1.3-1.9 mM (Fig. 1, Table 1). These 
values are comparable to published values obtained under different solution conditions.
22, 45
  
 
Transient kinetic analysis of the Dbp5 ATPase cycle 
To define the rate limiting steps within the intrinsic Dbp5 ATPase cycle, a combination 
of kinetic assays were used to measure individual rate and equilibrium constants. As described 
below, binding and dissociation of unlabeled nucleotides (ATP and ADP) were measured by 
competition with mant-labeled nucleotides, and constants related to ATP hydrolysis and product 
release were measured with PiBiP and oxygen isotope exchange assays. 
 
Dbp5 nucleotide binding and dissociation – The Förster Resonance Energy Transfer 
(FRET)-based fluorescence enhancement associated with mant-labeled nucleotide binding has 
been successfully used as a spectroscopic probe to characterize the ATPase cycles of DNA
33, 35, 
46-49
 and RNA helicases,
13, 14, 30
, myosin,
50-54
 and kinesin
32, 34, 55, 56
 motor proteins, as well as G-
proteins,
57-59
 with modest perturbations introduced by the mant moiety. We monitored mant-
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labeled ATP and ADP binding to Dbp5 from changes in FRET between Dbp5 tryptophans and 
the mant fluorophore. Time courses of fluorescence enhancement after rapidly mixing mantATP 
with Dbp5 was described by a sum of three exponentials (Fig. 2a and 2b, Supplementary 
Information), while mantADP binding was described by a sum of two exponentials (Fig. 2c and 
2d, Supplementary Information). The multi-exponential behavior did not arise from the mixed 
mant isomers (Supplementary Information) and was therefore modeled as two (mantADP) or 
three (mantATP) detectable and sequential biochemical transitions. In the case of mantATP, the 
[mantATP]-dependence of the three observed rate constants yields both forward and reverse rate 
constants (k+mTi and k−mTi, i=1, 2, 3. Table 1, Supplementary Information). The mantATP binding 
affinity (KmT; the mantATP equivalent of KT in Scheme 1, see Materials and Methods) 
determined from the ratio of k−mT1/k+mT1 is 7 µM (Table 1).  
The overall mantATP binding affinity (KmT,overall, a composite representing mantATP 
binding and successively populated transitions) is in the range of 1 µM (Table 1), several orders 
of magnitude tighter than the KM of unlabeled ATP (KM,ATP = 1.3-1.7 mM; Table 1) or the ATP 
binding affinity (1-2 mM) determined by NMR
45
 and this study (discussed below). The >240-
fold difference between mantATP and ATP binding affinities suggests that the mant fluorophore 
affects nucleotide binding to Dbp5
33, 35
. To identify the molecular origins of potential 
perturbations introduced by the mant moiety, we determined the structure of Dbp5 with bound 
mant-nucleotide. 
 
RNA/mantADP•BeF3-bound Dbp5 is structurally similar to RNA/ADP•BeF3-bound Dbp5 
– The structure of Dbp5 with bound nucleotide has not been determined by X-ray 
crystallography, but the structure of Dbp5 with bound ATP analog (ADP•BeF3) and RNA has 
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been reported.
27
 Therefore, we determined the structure of Dbp5 with bound mantADP•BeF3 and 
RNA, to assess the influence of the mant moiety and to identify any structural perturbations in 
the complex. 
The crystal structure of RNA/mantADP•BeF3-bound Dbp5, refined to a resolution 1.8 Å, 
reveals hydrophobic interactions between the mant moiety and three adjacent residues (Met110, 
Phe112, and Val181; Fig. 3a). Binding of mantADP buries 3,397 Å
2
 of the solvent accessible 
surface area of Dbp5, with the mant moiety of the ligand accounting for 511 Å
2
. If we assume 
that such change in hydrophobic surface area provides -15 ± 1.2 cal mol
-1
 Å
-2
 (Ref.  
60
), the 
additional contacts made by the mant fluorophore could potentially provide a total of 7.6 kcal 
mol
-1
 to the binding free energy. The mant moiety would therefore increase the ATP affinity 
from 6.4 mM (Go' = 3.0 kcal mol-1) to 20 nM (Go' = 10.6 kcal mol-1) and the ADP affinity 
from 360 µM (Go' = 4.8 kcal mol-1) to 1 nM (Go' = 12.4 kcal mol-1). Although these mant 
nucleotide binding constants are considerably tighter than observed (Table 1), it demonstrates 
that hydrophobic interactions with the mant moiety can account for the tighter binding affinity.  
Superposition of RNA/mantADP•BeF3-bound Dbp5 onto RNA/ADP•BeF3-bound Dbp5 
(PDB ID 3PEY) reveals a similar overall structure of the ATPase and bound ligands (rmsdC-α = 
0.1106, rmsdall-atom = 0.3939)
27
, suggesting that structural perturbations of Dbp5 and RNA 
introduced by the mant moiety are minimal (Figs. S4 and S5). One notable difference between 
the superimposed structures is the displacement of a set of eight water molecules found in the 
nucleotide-binding site of the ADP•BeF3-bound structure by the mant moiety (Fig. 3b), which 
may further contribute to the differences in mant nucleotide binding.  
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Unlabeled nucleotide binding to Dbp5– Kinetic competition between mantATP or 
mantADP and unlabeled ATP was performed to obtain parameters for unlabeled ATP binding 
and dissociation. ATP slows all observed rate constants associated with mantATP and mantADP 
binding (Fig. 4; Table 1), consistent with ATP binding in a rapid equilibrium (>300 s
-1
) and 
competing with mant-nucleotides for Dbp5 binding.
51, 61
 Rapid ATP binding kinetics are beyond 
stopped flow detection limits (~ 2 ms), so we used the reduction in kmT1,obs with increasing [ATP] 
to estimate an unlabeled ATP binding affinity (KT) of 6 mM (Fig. 4b, Eq. 13, Table 1). 
Competition with mantADP yields an ATP affinity of 3 mM (Fig. 4, Table 1).  The comparable 
(i.e. < 2-fold difference) ATP binding affinities determined from competition with mantATP or 
mantADP suggests that mantATP turnover (i.e. hydrolysis, product release and any steady state 
ATPase activity) occurs much more slowly than initial binding of ATP and does not affect the 
measured KT (see Supplementary Information).  
Kinetic competition between mantADP and ADP demonstrates that Dbp5 binds ADP in 
rapid equilibrium, but ~10-fold more tightly than ATP (KD = 360 µM, Table 1; Fig. 4), in 
agreement with published values (400-570 µM).
45
 Thus, mant-labeled nucleotides bind Dbp5 
more tightly than their unlabeled counterparts (Table 1). The multiple observed phases in mant-
nucleotide binding, particularly those of mantADP binding, may reflect isomerization steps 
facilitated by additional interactions between Dbp5 and the fluorophore. These isomerizations 
may contribute to high-affinity binding of mant-labeled nucleotides. 
 
Dbp5 ATP hydrolysis and phosphate release– Fluorescently labeled phosphate binding 
protein (PiBiP) has been used to measure transient Pi release from DBPs
 
and other molecular 
motor proteins.
13, 14, 44, 53
 Its tight binding of Pi (Kd = 0.1 µM) and rapid association rate constant 
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(> 3×10
8
 M
-1
 s
-1
) provides real-time fluorescent detection of transient and steady-state Pi 
release.
62
 Time courses of PiBiP fluorescence enhancement after rapidly mixing Dbp5 with ATP 
display multiple phases. The most prominent features are a lag followed by a linear phase (Fig. 
5). The linear portion corresponds to steady-state ATPase cycling. The steady-state cycling 
parameters (kcat = 0.08 s
-1
, KM,ATP = 1.3 mM) obtained from fitting the [ATP]-dependence of the 
turnover rate (i.e. the slope of the linear regime) to Eq. 10 agree well with those obtained with 
the NADH-coupled assay (Table 1), providing independent determination of the steady-state 
parameters (Table 1).  
The lag phase is defined by an observed rate constant whose value depends 
hyperbolically on the [ATP], yielding an ATP binding affinity (KT) of 4 mM (Fig. 5, Eq. 15), 
comparable to the values obtained by competition with mantATP and mantADP (Fig. 4). The 
observed lag phase rate constant at saturating ATP () has a value of 2 s
-1
 and corresponds to 
the sum of the ATP hydrolysis and Pi release rate constants (Scheme 1) as follows:
13, 14
 
    H H Pik k k          Equation 1.  
The intercept of the lag phase at zero ATP (0) is defined by: 
   
0
T H T Pi H Pi
T
H Pi
H Pi
T
k k k k k k
k
k k
k k
k
      

 
 

 

 
    Equation 2 
and has a value of ~0.02 s
-1
, though this is subject to experimental uncertainty since it is close to 
the origin.  When ATP dissociation is rapid (k−T >> other rate constants preceding ADP release 
in Scheme 1, a condition that is fulfilled since ATP binds in rapid equilibrium), the net 
contributions from the third term (k+Hk−Pi/k−T) of Eq. 2 are negligible and 0 simplifies to the sum 
of ATP resynthesis (k−H) and Pi release (k−Pi) rate constants: 
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     0 ~ H Pik k       Equation 3  
Combining Eqs. 1 and 3 allows the observed lag phase rate constant to be expressed as: 
 
     0~ Hk         Equation 4. 
 Given the values of  (~2 s
-1
) and 0 (~0.02 s
-1
), we conclude that ATP hydrolysis (k+H) 
dominates  and occurs with a rate constant of ~ 2 s
-1
 (Table 1). This and a steady state cycling 
kcat of 0.08 s
-1
 indicate that ATP hydrolysis is not rate limiting, though it can contribute to the 
value of kcat.
13-15
  
 
Oxygen isotope exchange – Oxygen isotopic exchange experiments were performed to 
determine the ratio between reverse hydrolysis (kH) and phosphate release (kPi). After 
hydrolysis, Dbp5 with bound ADP-Pi will either release Pi or resynthesize ATP, depending on 
the relative rate constants for Pi release and reverse hydrolysis. In each ATP hydrolysis event, a 
water-derived oxygen is incorporated into the liberated Pi and there is a defined probability 
(depending on the solution enrichment of 
18
O) that the water-derived oxygen is a heavy isotope. 
Therefore, the 
18
O isotope content in the released Pi product reveals the number of hydrolysis 
events that occurred before Pi release and determine the probability ratio of ATP resynthesis 
versus phosphate release.
13, 15, 61, 63
 In the absence of significant reverse hydrolysis, Pi will have a 
single water-derived oxygen, but significant reverse hydrolysis will generate Pi with multiple 
water-derived oxygens due to multiple rounds of hydrolysis and resynthesis prior to Pi release.  
The Pc value is determined by measuring the relative populations of singly and multiply-
labeled 
18
O phosphates, and is defined by the ATP resynthesis and Pi release constants according 
to
61, 63, 64
: 
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H
c
H Pi
k
P
k k

 


    Equation 5. 
The ratio of the 
18
O2:
18
O1 species was 0.0101 ±0.0009 for hydrolysis by Dbp5 (see Materials and 
Methods for full description of data analysis).  This ratio corresponds to a Pc value of 0.0113 
±0.0026 for hydrolysis in 48.5% 
18
O-water, indicating that Pi release occurs almost 100-fold 
faster than reverse hydrolysis (k−Pi/k−H = 99) and little ATP resynthesis occurs during steady-
state cycling. Consequently, the y-intercept of the lag phase rate constant 0 (Eq. 2) is dominated 
by k−Pi with a value of ~0.02 s
-1
, and a k−H value of 0.0002 s
-1
 (Eq. 3; Table 1). Thus, Dbp5 
hydrolysis is essentially irreversible despite slow Pi release. The determined value of the 
phosphate release rate constant of k−Pi ~0.02 s
-1
 is comparable to the steady state cycling rate, 
suggesting it or a transition preceding rapid Pi release limits Dbp5 cycling.  
 
Pi rebinding during ATPase cycling – To assess if Pi rebinding contributes to overall 
Dbp5 ATPase cycling and to estimate the Pi rebinding rate constant, we used the NADH assay 
(Pi release is irreversible in the PiBiP assay due to PiBiP and mop) to measure Dbp5 steady-state 
ATPase activity over a wide range of added free Pi. The Dbp5 ATPase activity is not affected by 
inclusion of Pi up to 10 mM, yielding an apparent ,
[ ][ ]
[ ]
i
Pi SS
i
P HD
K
HDP
  value >10 mM during 
steady-state cycling and making Pi release essentially irreversible.  
Although the steady-state distributions of the biochemical states are not identical to the 
equilibrium distributions, it is possible to relate this apparent KPi,SS to the true equilibrium 
constant ( ,
Pi
Pi eq
Pi
k
K
k


 ) with consideration of reaction flux. During initial steady state cycling, 
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the reaction flux at every transition (Scheme 1) is constant and equal to the observed product 
release rate, v0 (Eq. 10). For Pi release and rebinding, this is given by the expression 
 0[ ] [ ][ ] [ ]Pi i Pi i T catk HDP k P HD v H k     Equation 6. 
Dividing both sides of Eq. 6 by k+Pi[HDPi], rearranging terms, and substituting in the steady-
state and equilibrium definitions of KPi yields  
 
0 0
, , ,
[ ][ ]
[ ] [ ] [ ]
Pi i
Pi eq Pi SS Pi SS
Pi i Pi i Pi i
k P HD v v
K K K
k HDP k HDP k HDP

  
     
 
Equation 7, 
indicating that the affinity of Pi at equilibrium is always weaker than that in steady state. 
Therefore, since KPi,eq > 10 mM and k−Pi ~0.02 s
-1
, k+Pi must be slower than 2 × 10
-6
 s
-1
. These 
data suggest that Pi rebinding by Dbp5 is negligible under our assay conditions and does not 
result in substantial product inhibition, even in the absence of the Pi mop.  
 
Kinetic simulations from global fitting 
Our transient kinetic analysis indicates that the intrinsic ATPase cycle of Dbp5 features 
rapid, weak ATP binding, moderately slow hydrolysis, and rate-limiting Pi release followed by 
rapid ADP dissociation. To verify the experimentally determined rate and equilibrium constants, 
we globally fit ATPase time courses acquired with NADH and PiBiP assays (Figs. 1 and 5) at 
different [Dbp5] and [ATP] to Scheme 1 using KinTek Explorer software. All the rate constants 
in Scheme 1 were unconstrained in global fitting with the exception of the following ratios: the 
ATP and ADP binding affinities (defined by the ratio of k−/k+) were constrained to the 
experimentally determined values of 6 mM and 310 µM, respectively, and Pi release was 
constrained to a value ~100-fold faster than reverse hydrolysis. Our only fully constrained rate 
constant was Pi rebinding, which was set at a near-zero value since Pi release from Dbp5 is 
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essentially irreversible during steady-state cycling (and is irreversible in the presence of PiBiP). 
The fundamental rate constants obtained from global fitting (Table 2) agree well with the 
experimentally determined rate constants (Table 1) and account for the experimental time 
courses for various assays.  
Global fits by KinTek Explorer closely match the experimental NADH assay data (Fig. 1) 
when Pi release is either partially or solely rate-limiting. The requirement for two partially rate-
limiting steps (from the distinguishing lag phase in transient phosphate release assays; Fig. 5) 
eliminates scenarios in which hydrolysis does not also contribute to kcat. In support of this 
scheme, simulations generated from global fitting outputs are very sensitive to changes in both 
ATP hydrolysis/resynthesis and Pi release, but insensitive to changes in ATP/ADP binding and 
dissociation provided that those steps are much faster than hydrolysis and Pi release. The best 
global fit of the NADH experimental data was achieved with ATP hydrolysis (k+H) at 0.16 s
-1
, 
ATP resynthesis (k−H) at 6  10
-5
 s
-1
, and Pi release (k−Pi) at 0.06 s
-1
 with minimal phosphate 
rebinding (k+Pi ~ 0), thereby making Pi release the major determinant of kcat (Table 2). 
We also globally fitted transient Pi release data (Fig. 5) with thermodynamically 
constrained rapid ATP/ADP binding and dissociation, and a Pc value of 0.01. Independent of the 
steady-state NADH assay global fits by KinTek Explorer, the transient Pi release time courses 
are best globally fitted by a mechanism in which Pi release is the major determinant of kcat : ATP 
hydrolysis (k+H) occurs at 0.62 s
-1
, ATP resynthesis (k−H) at 0.001 s
-1
, and Pi release (k−Pi) at 0.1 s
-
1
. Constraining ATP hydrolysis (k+H) to 0.16 s
-1
 (the best global fit output from the NADH assay 
data) yields simulation outputs that overlay with the PiBiP data (Table 2, Fig. 5). Once again, in 
all converged parameters, Pi release limits the kcat of Dbp5. 
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 The steady-state cycling parameters kcat and KM,ATP can also be calculated from 
fundamental rate constants, but the relationship depends on the kinetic scheme. Using a minimal 
4-state model (Scheme 1), making no assumptions about the speed or reversibility of any of the 
associated transitions, the theoretical kcat and KM,ATP values are given by:
13, 65
  
 
( )( )
H Pi D
cat
H H Pi D H Pi Pi D
k k k
k
k k k k k k k k
  
       

   
   Equation 8 
 
  
    ,
T H Pi D Pi D H Pi D
M ATP
T H H Pi D H Pi Pi D
k k k k k k k k k
K
k k k k k k k k k
        
       
  

   
  Equation 9 
 
Substituting the rate constants derived from global fitting of either steady-state NADH or PiBiP 
assays (Table 2) into the above equations yield a kcat of 0.04 s
-1
 and a KM,ATP of 1.1 mM, which 
closely match our experimental steady-state data (0.04-0.08 s
-1
 and 1.3-1.5 mM, respectively; 
Table 1).  
In summary, the rate constants determined from globally fitting our experimental data to 
Scheme 1 (Table 2) are consistent with those determined experimentally (Table 1). Moreover, 
the global enzyme cycling parameters, kcat and KM, calculated using individual rate constants 
obtained from global fitting are comparable to the values determined experimentally. The high 
degree of agreement between experimentally-derived parameters (both steady-state ATPase and 
transient kinetics) and global fitting outputs demonstrates the robustness of the proposed kinetic 
scheme and the experimentally determined parameters. As such, the minimal ATPase scheme 
used here to model Dbp5 activity is sufficient to account for all observed transitions, and serves 
as a quantitative framework for evaluating the influence of RNA and regulatory factors.  
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B. Alteration of the intrinsic Dbp5 ATPase cycle by RNA 
Pi release in the presence of RNA  
RNA significantly impacts the Dbp5 ATPase cycle.
22
 To quantify these changes within 
the framework described thus far, we performed steady-state ATPase assays with Dbp5 in the 
presence of saturating levels of ATP (20 mM) and varying RNA (up to 7 mM), which resulted in 
a ~20- fold acceleration of kcat (0.92±0.08 s
-1
), confirming earlier studies (Fig. 6, Table 1).
22
 
Given that intrinsic Dbp5 ATPase cycling is mainly limited by Pi release, RNA must minimally 
accelerate Pi release 20-fold to achieve this increase in kcat. We therefore evaluated if RNA had 
the predicted effect on Pi release, and also whether or not our modeled rate constants from 
Scheme 1 were predictive of overall intrinsic Dbp5 steady-state cycling. 
Pi release is primarily rate-limiting in the absence of RNA and other cofactors. Therefore, 
the majority of Dbp5 populates the ADP-Pi state under in vitro steady-state cycling conditions 
(Fig. 7). We took advantage of this Dbp5-ADP-Pi accumulation in a series of dual-mixing 
experiments to test the effects of RNA on Pi release from the pre-formed Dbp5-ADP-Pi state. 
Dbp5 was first rapidly mixed with ATP and ―aged‖ for various times to allow biochemical 
intermediates along the ATPase cycle to form, then rapidly mixed again with a range of [RNA] 
while monitoring Pi release with PiBiP. Based on the intrinsic rates determined above, delay 
times of 0.05 s, 6 s, and 25 s should result in progressive Dbp5 population of ATP-bound (pre-
hydrolysis), ADP-Pi -bound (post-hydrolysis), and ADP-bound (post Pi release) states, 
respectively.  
Delay times ≥ 6 s abolished the lag phase in PiBiP fluorescence time courses with Dbp5 
alone (i.e. no RNA; Fig 8a). This observation is consistent with formation of the post-hydrolysis 
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ADP-Pi state during aging, thereby bypassing (at least) one of the transitions contributing to the 
lag phase observed in single mixing experiments (Fig. 5). Furthermore, a rapid burst of PiBiP 
fluorescence was observed with longer delay times (25 s, Fig. 8a), consistent with PiBiP binding 
to Pi liberated by Dbp5 via hydrolysis events that occurred during aging. From these data, we can 
conclude that our modeled rate constants for intrinsic Dbp5 cycling are predictive of actual Dbp5 
behavior and that these dual-mixing experiments can be used to interrogate the effect of RNA on 
Pi release. 
Upon addition of RNA in the second mix after aging, time courses of PiBiP fluorescence 
display a lag phase followed by a linear phase (Fig. 8b), independent of the age time (from 0 to 
25 s) even if the lag is absent from time courses with Dbp5 alone (e.g. 6 s age time). The lag 
phase observed rate constant with 10 mM RNA is ~4-6 s
-1
 for all aging periods examined.  The 
lag phase observed rate constant also depends hyperbolically on [RNA], reaching a maximum 
value of ~5.5 (±2) s
-1
 at saturating [RNA] (Fig. 8c).Thus, RNA alters the hydrolysis cycle of 
Dbp5 by introducing two or more new rate-limiting steps, at least one of which does not depend 
on pre-population of a particular Dbp5-nucleotide bound state. This is most likely an RNA 
binding-dependent transition — either slow RNA binding or a slow isomerization following 
binding — which must occur prior to establishing a new steady-state.  
The [RNA]-dependence of the lag (Fig. 8c) is presumably related to the RNA affinity 
(Kd,RNA) of Dbp5 (with bound nucleotide) at sub-saturating [ATP], and its value of 3 (±3) mM 
agrees well with the Michaelis constant KM,RNA
14
 of 3.4 (±0.8) mM for [RNA] dependent Dbp5 
ATPase obtained from steady-state NADH assays (Fig. 6b, Table 1). The lack of a Pi burst from 
the pre-formed Dbp5-ADP-Pi state following RNA binding (delay times ≥ 6 s, Fig. 8b) also 
establishes that Pi release must continue to be slow and partially rate-limiting, even when RNA is 
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present. However, we note that the dual-mixing experiments do not rule out the possibility that 
hydrolysis may also limit kcat in the presence of RNA. We therefore conclude that at least two 
biochemical transitions — an isomerization associated with RNA binding, and Pi release — limit 
RNA-activated Dbp5 ATPase cycling.  
    
Oxygen isotope exchange in the presence of RNA 
 RNA may also promote ATP hydrolysis by Dbp5, as with other DBPs.
8, 66, 67
 A faster 
observed hydrolysis rate constant could result from accelerated ATP resynthesis, ATP 
hydrolysis, or both. The very slow rate of ATP resynthesis in the intrinsic Dbp5 ATPase cycle 
makes the first option a distinct possibility, and this is crucial to understanding the potential 
effects of other regulators. We therefore performed oxygen isotope exchange analysis of the 
RNA-activated, steady-state Dbp5 ATPase.  
The Pc value in the presence of RNA is 0.042 ± 0.003 (vs. 0.01 in the absence of RNA), 
which equates to a Pi release rate constant that is ~25-fold faster than ATP resynthesis (Table 1).  
Because Pi release is accelerated 20-fold in the presence of RNA, ATP resynthesis must also be 
accelerated to maintain the observed 4-fold difference in Pc value. Using the rate constants for Pi 
release, the Pc values and Eq. 5, we estimate that RNA accelerates ATP resynthesis by Dbp5 
~80-fold. Accelerating ATP resynthesis increases the observed ATP hydrolysis rate constant (i.e. 
shortens ATP hydrolysis relaxation time), as it is determined by the sum of forward and reverse 
rate constants.
68
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DISCUSSION 
General features of the intrinsic Dbp5 ATPase cycle 
Dbp5 has a slow maximum turnover rate (kcat ‒ 0.04 s
-1
) and a weak KM,ATP (1.3-1.9 mM). 
The slow kcat results from slow ATP hydrolysis coupled to even slower Pi release, both of which 
limit overall cycling, though Pi release is the major determinant. It is experimentally difficult to 
measure hydrolysis directly by chemical quench-flow,
13, 66, 69
 given weak ATP binding to Dbp5 
(i.e. saturation requires ~20 mM ATP, a small fraction of which will be hydrolyzed even with 
tens of micromolar Dbp5, making detection by thin layer chromatography, HPLC, and other 
conventional means technically challenging). However, isotope exchange experiments and the 
presence of the lag in PiBiP fluorescence time courses provide sufficient evidence to implicate 
both hydrolysis and Pi release as slow and relatively irreversible transitions that limit Dbp5 
ATPase cycling in the absence of RNA and other regulatory factors. Current structural and 
biochemical data support a role for protein regulators (i.e. Gle1-InsP6 and Nup159) in facilitating 
enzyme recycling post-hydrolysis,
25, 27
 which fits well with the kinetic bottlenecks identified 
here. Future studies will be required to investigate if these regulators function in this fashion 
and/or facilitate other transitions in the ATPase cycle that become limiting in the presence of 
RNA and trans-activating factors.   
 
Interactions with mant-labeled nucleotides 
We found that mant-labeled nucleotides severely perturb the kinetics and 
thermodynamics of the Dbp5 ATPase cycle.  The rate and equilibrium constants are affected by 
several orders of magnitude and the rate-limiting transitions for intrinsic cycling are also 
perturbed (Supplementary Information).  This is the first example to our knowledge of such 
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dramatic differences in behaviors between native and mant-labeled nucleotides with the DBP 
family of enzymes. While the origin of this fluorophore effect is still unclear, additional 
hydrophobic interactions with the mant fluorophore (Fig. 3, Supplementary Information) are 
likely to contribute. It is intriguing to speculate if the ability of Dbp5 to discriminate between 
ATP and ATP-like molecules may serve some additional function in vivo, as was recently 
described for the DBP Ded1 in AMP sensing.
70
 Certainly, it demonstrates that fluorophore 
effects are not uniform even between closely related enzymes and must be checked.
33, 35, 48
 
 
General features of the Dbp5 RNA-stimulated ATPase cycle 
Dbp5 steady state ATPase cycling is accelerated 20-fold by RNA (Table 1). 
Consequently, the main rate limiting step in the intrinsic Dbp5 cycle — Pi release — must be 
accelerated by RNA at least 20-fold. Intriguingly, RNA binding (kHT+R = 1-5 s
-1
) becomes 
partially rate-limiting, and together with Pi release (k−RPi = 1-5 s
-1
), limits steady state Dbp5 
ATPase cycling in the presence of RNA. This suggests the interaction time between Dbp5 and 
RNA is ≥ 0.4 s (
1 1
1 1 1 1
0.4 s
5 s 5 si
RNA binding P release
HT R RPik k
    
 
      ), which may be 
significant for the role of Dbp5 in mRNA export (see discussion below) and/or other cellular 
processes.  
 
Comparison to other DBPs 
The intrinsic Dbp5 ATPase cycle appears very similar to that of other RNA helicases. 
Like Dbp5, both DbpA and Mss116 display unfavorable hydrolysis and fully or partially rate-
limiting Pi release in the absence of RNA.
13-15
 In the case of DbpA, hydrolysis is so unfavorable 
that it is undetectable in the absence of its RNA activator, the peptidyl-transferase center (PTC) 
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of the 23S ribosomal RNA.
13, 15, 71
 Although the equilibrium constants for ATP hydrolysis (KH) 
and Pi release (KPi) of intrinsic Dbp5 ATPase activity actually favor progression through the 
ATPase cycle, the slow rate constants associated with both transitions bottleneck the intrinsic 
cycle at similar positions (i.e. biochemical states) as with DbpA and Mss116 cycling. In this 
sense, Dbp5 appears to be typical of the DBP family.   
Despite these similarities with other representative DEAD-box proteins, some unique 
features of Dbp5 should be noted. First is the extremely weak millimolar ATP binding affinity 
(~4 mM) as compared to sub-millimolar binding affinities for most other studied DBPs.
13, 14
 As a 
result, little Dbp5-ATP is populated under physiological conditions;
72, 73
 rather, free Dbp5, 
Dbp5-ADP-Pi and Dbp5-ADP are favored (Fig. 7).  
A second feature of the intrinsic ATPase cycle of Dbp5 is the slow reverse hydrolysis 
(ATP resynthesis) rate constant both in the presence and absence of RNA, which maintains Dbp5 
in an ADP-Pi state when coupled with even slower Pi release (Fig. 7). Although accelerated at 
least 20-fold with RNA, Pi release remains at least partially rate-limiting, such that Dbp5 
significantly populates the ADP-Pi state even in the presence of RNA. Formation of such a 
stabilized biochemical intermediate may promote distinct and/or high affinity interactions with 
RNAs important for in vivo function, as with other DBPs,
10, 13-15
 which may be required for the 
proposed ribonucleoprotein (RNP) remodeling activity of Dbp5 at NPCs.
74-76
  
Alternatively, it has been demonstrated that Dbp5 shuttles through the nucleus,
19
 interacts 
with transcriptional machinery,
39
 and travels with nuclear RNPs from the site of transcription to 
NPCs 
37
. This latter activity may rely on Dbp5 acting as an ATP-dependent RNA clamp and 
remaining bound to an mRNA, similar to eIFAIII as part of the exon-junction complex.
9
 
Maintenance of Dbp5 in an RNA-bound state would allow Dbp5 to be loaded on to mRNPs in 
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the nucleus during mRNP biogenesis and subsequently released upon reaching the cytoplasmic 
side of an NPC where known regulators (i.e. Gle1 and Nup159) are located, resulting in spatial 
regulation of the Dbp5 ATPase cycle. Within such a model, completion of the ATPase cycle 
only upon exiting the nucleus would facilitate directional mRNP export by initiating disruption 
of the Dbp5-RNP scaffold and mRNP remodeling. mRNA export times are reported to be in the 
range of a few hundred milliseconds
77-80
, as such the ability of Dbp5 to remain bound to RNA for 
≥ 400 milliseconds is consistent with a clamp model for Dbp5 in mRNA export. To distinguish 
amongst these possibilities related to mRNA export and to understand how Dbp5 functions in 
other cellular processes, it will be critical to continue to investigate how regulators individually, 
and in combination, alter the Dbp5 ATPase cycle.  
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MATERIALS AND METHODS 
 
Chemicals 
All chemical reagents were of the highest purity commercially available. Millipore 
MiliQ® water (filtered through 0.2 µm filter) or Sigma RNAse-free water was used in all 
buffers. ATP (Sigma A7699, ≥ 99% purity assayed by HPLC, ≤ 0.1% inorganic phosphate) and 
ADP (Roche Molecular Biochemicals) concentrations were determined by absorbance using ε259 
of 15,400 M
-1
 cm
-1
. Polyuridylic acid (polyU RNA) (Santa Cruz Biotechnology, SC-215733A) 
was dialyzed extensively against distilled deionized water and ethanol precipitated prior to use. 
RNA concentrations were determined by absorbance using ε260 of 9660 M
-1
 cm
-1
 and are in units 
of nucleotides. Mant-labeled nucleotides (2' and 3' mixed isomer, mantATP and mantADP from 
Invitrogen and mantATP, mant-dATP and mant-dADP from Jena Biosciences) concentrations 
were determined by absorbance (ε255 = 23,300 M
-1
 cm
-1
).  One molar equivalent of MgCl2 was 
added to all nucleotides immediately before use. 
All assays were performed at 25 ± 0.1 °C in 30 mM HEPES, pH 7.5, 100 mM KCl, 2 
mM MgCl2, and 2 mM DTT. 
 
Protein Expression, Purification and Labeling 
N-terminal 6xHis tagged Dbp5 was expressed and purified from Escherichia coli as 
previously described 
81
. The E. coli phosphate binding protein (PiBiP) was purified and labeled 
with MDCC (7-diethylamino-3-(((2-maleimidyl)ethyl)amino)carbonyl) coumarin; Thermo 
Fisher Scientific Inc.) as described.
44, 82
   
 
Protein Crystallization 
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Dbp5 crystal structures used the construct ∆90Dbp5 (Dbp5 residues 91-482) instead of 
full-length Dbp5
27
, purified as described above. In preparation for crystallization, ∆90Dbp5 was 
dialyzed into 30 mM HEPES, pH 7.5, 400 mM NaCl, 1 mM DTT, 0.25 mM InsP6 in 10% 
glycerol as previously described.
27
 The N-terminal 6xHis tag was cleaved overnight at 4 ˚C with 
tobacco etch virus (TEV) protease in 5 mM DTT. Cleaved ∆90Dbp5 was purified by nickel 
affinity chromatography with Ni
2+
-NTA agarose (Qiagen) followed by size exclusion 
chromatography over a Superdex 200 (10/300) GL column (GE Healthcare) in 10 mM HEPES, 
pH 7.5, 100 mM NaCl, 1 mM DTT, 0.25 mM InsP6
 in 10% glycerol. Purified ∆90Dbp5 was 
concentrated after the addition of 5 mM MgCl2. The ∆90Dbp5-mantADP•BeF3 complex was 
formed by mixing concentrated ∆90Dbp5 in solution with a 1.2:1 molar ratio of rU10 RNA 
(IDT), incubating 15 min, and then mixing mantADP•BeF3 (prepared in a 1:3:15 ratio of 
ADP:Be:F) to a final concentration of 1 mM, followed by another 15 min incubation. 
Crystallization of ∆90Dbp5-mantADP•BeF3 was performed by hanging drop vapor diffusion at 
18 ˚C by mixing 100 nL of the complex at a protein concentration of 16 mg mL-1 with 100 nL of 
reservoir solution containing 200 mM Mg(NO3)2 and 18% PEG 3350 and incubating 4 days over 
100 µL of reservoir solution in a sealed chamber. Crystals were transferred to a cryoprotectant 
solution containing 18% PEG 3350, 9 mM HEPES, pH 7.5, 180 mM Mg(NO3)2, 4.5% glycerol, 
1 mM DTT, 90 mM NaCl, 0.25 mM InsP6, 4.5 mM MgCl2 and 1 mM mantADP•BeF3 (prepared 
in a 1:3:15 ration of ADP:Be:F), and flash frozen in liquid nitrogen. 
 
Crystallographic Data Collection, Structure Determination, and Refinement 
Data were collected at 100 K on the NECAT 24-ID-E beam line of the Advanced Photon 
Source at the Argonne National Laboratory and processed with HKL.
83
 Crystals belonged to the 
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space group P212121. The structure of ∆90Dbp5-mantADP•BeF3 was determined by molecular 
replacement with Phaser using the entire Dbp5 subunit (PDB ID code 3PEY) as a search 
model.
84
 The atomic coordinates and temperature factors were refined with REFMAC5, initially 
with noncrystallographic symmetry restraints applied.
85
 The atomic model was improved with 
cycles of model building with COOT
86
 followed by positional refinement. Rigid-body motions 
were modeled with REFMAC5 in terms of TLS tensors for translation, libration, and screw-
rotation.
87
 Water molecules were added using an automated procedure in COOT and by visual 
inspection. A final round of refinement was done with PHENIX.
88
 Atomic coordinates and 
structure factors have been deposited in the Protein Data Bank under accession code 5ELX. See 
Table S2 for data collection and refinement statistics. 
 
Steady-state ATPase assays 
Time courses of Dbp5 (0.6-1 µM) steady state ATPase assayed by absorbance change at 
340 nm using the NADH-coupled assay were acquired on a Perkin-Elmer Lambda 20 UV-Vis 
spectrophotometer thermostatted at 25 °C.
13, 43, 66
 The [ATP]-dependence of the initial steady-
state ATPase rate (v0) was fitted to the Michaelis-Menten equation:  
     Equation 10 
where kcat is the maximal turnover rate of Dbp5 at saturating ATP in units of s
-1
, [H]T is the total 
Dbp5 concentration, KM,ATP is the Michaelis constant for ATP, and [T] is the total [ATP].  The 
[ADP] under our conditions of 2 mM ATP is ∼ 7 μM.43 Steady-state ATPase assays were also 
performed using ATPγS as a substrate. 
0
,
[ ] [ ]
[ ]
cat T
M ATP
k H T
v
T K


AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 27 
 RNA-stimulated steady-state ATPase experiments were performed as detailed above, 
using 100 nM Dbp5 and 20 mM ATP. Data was fitted to the quadratic form of the Briggs-
Haldane equation 
 
            
 
2
, ,
0 0
4
2
M RNA M RNAT T T T T T
obs cat
T
H R K H R K H R
v k k k
H
     
    Equation 11 
where [R]T is the total RNA concentration in nucleotides.
66
  
 
Transient kinetic assays 
Transient kinetic measurements were done with an Applied Photophysics SX-2.0 
stopped-flow apparatus thermostatted at 25 ± 0.1 °C.
13-15, 30, 66
 The time courses shown are either 
of raw, unaveraged traces or the average of 2-3 traces. The concentrations stated are final after 
mixing.  Uncertainties are reported as standard errors in the fits unless stated otherwise. The 
following minimal reaction scheme with corresponding fundamental rate (k) and equilibrium 
constants (K, defined by ratio of corresponding k values) was used for analysis and modeling: 
13-
15, 66
 
 
i
i
i i i
PT H D
T H P D
kk k k
k k k k
H T HT HDP HD P H D P
  
   
           Scheme 1 
where H is Dbp5, T is ATP, D is ADP, and Pi is inorganic phosphate. We assume product release 
is sequential with Pi preceding ADP. Several processes (e.g. nucleotide binding) are likely to be 
associated with multiple transitions (e.g. binding followed by an isomerization of the Dbp5-
nucleotide complex), but are omitted for simplicity.
8, 13-15, 66
 
 
Nucleotide binding 
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Time courses of mant-nucleotide binding were measured by Förster resonance energy 
transfer from Dbp5 tryptophans to bound nucleotides. Fluorescence (λex = 280 nm) was 
monitored through a 400 nm long pass colored filter. Inner filter effects from mant-nucleotide 
absorption are minimal at the mant-nucleotide concentrations used (< 120 µM). Time courses of 
association were acquired under both pseudo-first order and non-pseudo first order conditions.  
Data acquired under pseudo-first order conditions were fitted to a linear sum of exponentials. 
Time courses acquired under non-pseudo first order conditions were fitted with the following 
expression:
89
 
   Equation 12 
where F0 is the signal at time (t) = 0, A0 and k0 are the signal amplitude and observed rate 
constant of the first phase, and r is an indication of the deviation of the bimolecular binding term 
(the second term in Eq. 12) from a single exponential. Under pseudo-first order conditions, r 
approaches 0 and the second term collapses to an exponential. When pseudo-first order 
conditions are not observed, r approaches 1, creating significant deviations from a single 
exponential.
89
 The terms Ai and ki (i = 1, .., n) are the amplitudes and observed rate constants of 
additional phases following bimolecular binding, respectively. Irreversible mantADP 
dissociation was measured by rapidly mixing a pre-equilibrated mixture of 1 µM Dbp5 and 10 
µM mantADP with 1 mM ADP and the time courses of fluorescence change were fitted to a sum 
of exponentials.
51, 66
  
Unlabeled nucleotide binding was measured by kinetic competition with mant-labeled 
nucleotides.
35, 51
 Time courses of fluorescence change associated with mant-nucleotide binding 
after rapidly mixing 0.5-0.6 µM Dbp5 with a mixture of 20 or 50 µM mant-nucleotide (either 
mantADP or mantATP) and varying concentrations of unlabeled nucleotide (ATP or ADP) were 
 0
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fitted to a sum of exponentials. The unlabeled nucleotide binding affinity (dissociation 
equilibrium constant, Kd) was determined from the [unlabeled nucleotide]-dependence of the 
observed mant-nucleotide binding rate constant, as defined by: 
51, 64
 
0( )
[ ]
1
obs
d
k k
k k
N
K



 

    
 Equation 13 
where [N] is unlabeled nucleotide concentration, and k0 is the observed mant-nucleotide rate 
constant in the absence of competing unlabeled nucleotide ([N] = 0), and k∞ at saturating [N].   
 
Transient Pi release of intrinsic Dbp5 ATPase 
Phosphate release from Dbp5 was assayed from the eightfold increase in fluorescence 
(λex = 436 nm, 463 nm long pass colored glass emission filter) of the MDCC-labeled PiBiP upon 
binding phosphate. Contaminating Pi was removed from all equipment and buffers with a Pi 
―mop‖ consisting of 0.5 mM 7-methylguanosine and 0.01 U/mL purine nucleoside 
phosphorylase (Sigma). Since the process of mop’s scavenging free Pi in solution is very slow on 
the seconds time scale and PiBiP binds Pi much faster (<100 ms) and extremely tightly, the 
presence of mop has minimal effect on transient and steady-state Pi release measurements, 
especially at short timescales.
62
 Furthermore, 7-methylguanosine (up to 250 µM) does not alter 
mantATP binding kinetics (data not shown). PiBiP fluorescence was converted to [Pi] following 
calibration with phosphate standard solutions. Time courses of Pi liberation ([Pi]) measured after 
rapidly mixing 0.5 µM Dbp5 with an equilibrated mixture of 5 µM of PiBiP and varying ATP 
concentrations were fitted to the following expression defining a lag phase followed by a linear 
phase:
13, 14
 
        ,0
1
1i iP e t P


     
 
    Equation 14 
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The linear regime represents steady-state ATPase, and its slope (given by β) is the turnover rate.  
The lag phase is defined by an exponential with observed rate constant . The [ATP]-
dependence of the observed lag phase rate constant was fitted to a hyperbola in the following 
form:
13, 14
 
         Equation 15 
where [T] is the ATP concentration,  is the observed lag phase rate constant at saturating ATP, 
0 is the intercept value at zero ATP, and KT is the ATP dissociation equilibrium constant. 
 
RNA-stimulated transient Pi release of Dbp5 ATPase 
 Single-mix experiments were conducted above with the following modifications: 0.4 µM 
Dbp5 was pre-equilibrated with varying concentrations of RNA, and rapidly mixed with 2.5 mM 
ATP pre-equilibrated with 5 µM PiBiP. Pi mop was present in all solutions. Data was analyzed as 
detailed above.   
Dual-mix experiments were conducted as above, with the modification that all solutions 
contained both 5 µM PiBiP and Pi mop. Using the dual-mix mode of the SX20 stopped-flow, 5 
µM Dbp5 was mixed with 4 mM ATP and aged for 0.05, 6, or 25 s. After aging, the Dbp5/ATP 
solution was rapidly mixed with 0 or 10 mM RNA (nucleotide). Final concentrations were 2.5 
µM Dbp5, 2 mM ATP, 0 or 10 mM RNA, and 5 µM PiBiP. Time courses of [Pi] release in the 
absence of RNA were fit to a sum of bimolecular binding and a linear function. Time courses of 
[Pi] in the presence of RNA were fit to the following sum of bimolecular binding and combined 
lag/linear phase: 
    0
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Oxygen isotope exchange 
ATPase reactions (5-10 µM Dbp5, 5-10 mM ATP) were conducted in 5-6 mM 
phosphoenolpyruvate (PEP), 50 U mL
-1
 phosphoenolpyruvate kinase (PK), and 48.5% 
18
O-
labeled water. Reactions were run at room temperature for several hours to generate 2-3 mM Pi, 
then quenched with an equivalent volume of 1 N HCl. Pi was isolated and analyzed by coupled 
gas chromatography/mass spectrometry (GCMS).
61, 64
 GCMS analysis of Pi samples from 
hydrolysis of unlabeled ATP in 
18
O-enriched water yields the distribution of species with zero to 
four 
18
O-oxygens per Pi.  The Pc value was not determined by global fitting of this complete 
distribution because the starting reactions contained variable amounts of unenriched Pi that result 
in an excess of the 
18
O0 species.  At the low extents of reversal observed with Dbp5, most of the 
Pi contains only one water-derived oxygen with only a small amount of Pi that contains two 
water-derived oxygens.  The amount of the species with two water-derived oxygens increases 
with increasing Pc value.  The ratio of the 
18
O2:
18
O1 species with 2 versus 1 labeled oxygens was 
therefore used to determine Pc because this ratio only depends on the enrichment in the water 
and the Pc value and is uninfluenced by the amount of contaminating unenriched Pi.     
Oxygen isotope exchange experiments were also performed with RNA-stimulated Dbp5 
ATPase activity. Steady-state reactions in the presence of RNA used 2 µM Dbp5, 2.5 mM ATP, 
and 8 mM polyU RNA. Data was analyzed as above. 
 
Simulation of transient and steady-state activity 
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Kinetic simulations by global fitting of both steady-state ATPase time courses acquired 
with the NADH assay and transient/steady-state Pi release acquired by PiBiP fluorescence were 
done using Scheme 1 and KinTek Global Kinetic Explorer Software (KinTek Corp).
90, 91
 A rapid 
(>> kcat; e.g. ≥10 s
-1
) transition accounting for ATP regeneration from liberated ADP was also 
included to account for the activity of lactate dehydrogenase and phosphoenolpyruvate kinase in 
the NADH assay.   
 
Accession numbers 
 Coordinates of the crystal structure of Dbp5 bound to RNA and mantADP•BeF3 have 
been deposited in the Protein Data Bank under the accession number 5ELX. 
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Figure 1. Steady-state ATPase activity of Dbp5. (a) Time courses of absorbance change at 340 
nm assayed with the NADH-coupled assay after mixing 660 nM Dbp5 with (lower to upper 
curves) 0, 0.25, 0.5, 1, 2, 8, or 20 mM ATP. The continuous lines through the data represent the 
best fits to linear functions, yielding the steady-state ATPase rates from the slopes. The dashed 
lines represent kinetic simulations of Scheme 1 and the corresponding rate and equilibrium 
constants obtained from global fitting with Kintek Explorer in Table 2. (b) [ATP]-dependence of 
the Dbp5 steady state ATPase rate. The continuous line through the data represents the best fit to 
a rectangular hyperbola, yielding the maximum velocity per enzyme (kcat) from the amplitude 
and the KM,ATP from the [ATP] at half-maximum velocity (Table 1).  Uncertainty bars represent 
standard errors in the fits and are within the data points. 
 
 
Figure 2. mant-nucleotide binding to Dbp5. (a) Time courses of fluorescence change after 
mixing 0.5 µM Dbp5 with (lower to upper) 0,  2.5, 5, 10, 20, 30, or 50 µM mantATP. The 
smooth lines through the data represent the best fits to 3 exponentials.  (b) Full time courses from 
(a) shown on a log scale to 200 s. (c) [mantATP]-dependence of the observed rate constants 
associated with mant TP binding.  Continuous lines represent the best linear fits to the data.  
Uncertainty bars representing the standard errors of the best fits are within the data points. (d-f) 
Analogous mantADP binding data fitted to 2 exponentials shown on linear (d) and log (e) scales, 
and with rate constants fitted to hyperbolic or linear functions (f).  
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Figure 3. Interactions between mant-ADP•BeF3 and Dbp5. (a) The mant fluorophore buries 
adjacent residues (Val181, M110, and Phe112) of ∆90Dbp5 via hydrophobic interactions (<4.0 
Å).  The mant moiety hydrogen bonds (dashes) with waters at the solvent exposed surface. (b) 
Displacement of a network of hydrogen-bonded water molecules by the mant fluorophore. 
∆90Dbp5-ADP•BeF3 (blue) and the associated water molecules (red) of 3PEY superimposed 
to ∆90Dbp5-mant-ADP•BeF3 and the associated water molecules (grey). -stacking of the 
adenine is maintained. rmsd = 0.1106 Å. 
 
 
Figure 4. Unlabeled nucleotide binding affinity measured by competition with mant nucleotides. 
(a) Time courses of fluorescence change after mixing 0.5 µM Dbp5 with 50 μM mantADP and 0, 
0.175 mM, 0.75 mM, 2 mM, 5 mM, or 10 mM ADP (upper to lower). Continuous lines through 
the data represent best fits to 2 exponentials. (b) [nucleotide] dependence of the fastest observed 
rate constant (k1,obs) after mixing 0.5 µM Dbp5 with a solution of 50 µM mantADP 
supplemented with 0, 0.1, 0.3, 0.6, 1, 2.5, 5, or 11 mM ATP (black squares).  Black circles 
represent the fastest observed rate constant of mantADP binding on mixing 0.5 µM Dbp5 with a 
solution of 50 µM mantADP supplemented with 0.005, 0.015, 0.03, 0.0625, 0.175, 0.75, 2, 5, or 
10 mM ADP.  Solid lines represent best fits to Eq. 13.  
 
 
Figure 5. Transient and steady-state Pi release during Dbp5 ATPase cycling. (a) Time courses of 
fluorescence change after mixing 0.5 µM Dbp5 with a 5 µM PiBiP containing (lower to upper 
curves) 0, 0.5, 1, 2, or 5 mM ATP. Fits to Eq. 14 are shown as dashed lines through the data. 
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Simulated data (using rate and equilibrium constants obtained from Kintek Explorer global 
fitting, Table 2) are shown as dotted lines through the data. (b) [ATP]-dependence of the 
observed Pi release lag phase rate constant (λ). Continuous line through the data points represents 
best fit to a rectangular hyperbola (Eq. 15).  
 
 
Figure 6. RNA-stimulated steady-state ATPase activity of Dbp5. Time courses of absorbance 
change at 340 nm assayed with the NADH-coupled assay after mixing 100 nM Dbp5 and 20 mM 
ATP with (lower to upper curves) 0, 0.45, 1.25, 2, 3, or 4.5 mM polyuridylic acid (concentration 
refers to total nucleotides). The continuous lines through the data represent the best fits to linear 
functions, yielding the steady-state ATPase rates from the slopes. (b) [ATP]-dependence of the 
RNA-stimulated Dbp5 steady state ATPase rate. The continuous line through the data represents 
the best fit to Eq. 11, yielding the maximum velocity per enzyme (kcat) from the amplitude and 
the KM,RNA from the [ATP] at half-maximum velocity (Table 1).  Uncertainty bars represent 
standard errors in the fits and are within the data points. 
 
 
Figure 7. Steady-state distribution of Dbp5 ATPase cycle intermediates. In vitro conditions are 
20 mM ATP, 0 mM ADP, 0 mM Pi. In vivo conditions are 2.1 mM ATP
72
, 470 µM ADP
72
, 2.5 
mM Pi
73
.  
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Figure 8.  Transient RNA-stimulated Pi release during Dbp5 ATPase cycling. (a) Time courses 
of fluorescence change after mixing 5 µM Dbp5 with 4 mM ATP and aging for (lower to upper) 
0.05 s, 6 s, or 25 s prior to rapidly mixing with 5 µM PiBiP. Dashed lines are best fits to (lower 
to upper) Eq. 14, linear equation, or bimolecular binding plus a linear phase, respectively. (b) 
Time courses of fluorescence change after mixing 5 µM Dbp5 with 4 mM ATP, aging for 6 s, 
and then rapidly mixing with 0 or 10 mM RNA in the presence of 5 µM PiBiP. Fits to Eq. 16 are 
shown as dashed lines through the data. (c) [RNA]-dependence of the observed Pi release lag 
phase rate constant (λ) where pre-equilibrated Dbp5 and RNA are rapidly mixed with ATP and 
PiBiP. Continuous line through the data points represents best fit to a rectangular hyperbola (Eq. 
15), yielding a maximum observed rate constant of 5.5 ±2 s
-1
 upon extrapolation of the fit to 
saturating RNA.  The [RNA] at half maximal is ~3 mM under these non-saturating ATP 
concentrations.  
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Table 1. Rate and equilibrium constants of the Dbp5 ATPase cycle. 
Parameter Value Units Assay 
Steady-state ATPase  
kcat 0.043 (±0.001) s
-1  NADH linked assay 
 
0.084 (±0.002) s-1 PiBiP  
 
   
KM,ATP 1.7 (±0.2) mM  NADH linked assay 
 
1.3 (±0.1) mM PiBiP  
    
Steady-state ATPase of ATPγS 
kcat 0.036 (±0.001) s
-1 NADH linked assay 
    
KM,ATPγS 0.98 (±0.06) mM NADH linked assay 
    
  
 
 ATP and mantATP binding  
k+mT1 1.63 (±0.04) µM
-1 s-1 mantATP 
k−mT1 11.9 (±0.7) s
-1 mantATP 
KmT1 7.3 (±0.4) µM k−/k+ 
k+mT2 0.4 (±0.6) s
-1 mantATP 
k−mT2 1.9 (±0.4) s
-1 mantATP 
KmT2 5 (±7)  
k−/k+ 
kmT3,obs 0.01 (±1 × 10
-4) s-1 mantATP 
KmT,overall 
1 (± 0.3) µM Total fluorescence amplitude 
KT 6.4 (±0.7) mM mantATP competition 
 3.0 (±0.4) mM mantADP competition 
 
4 (±2) mM PiBiP  
 
   
ATP hydrolysis 
k+H 2.2 (±0.4) s
-1 PiBiP  
k−H 2 × 10
-4 (±5 × 10-5) s-1 PiBiP & isotope exchange 
KH 1 x 10
-4 (±3 × 10-5) 
 
k−/k+ 
    
Phosphate release 
k−Pi 0.02 (±0.1) s
-1 PiBiP  
k+Pi < 2 × 10
-6 µM-1 s-1 k−Pi /KPi  
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KPi 10 mM Steady-state Pi inhibition  
    
ADP and mantADP binding 
KmD0 102 (± 21) µM mantADP 
k+mD1 98 (±15)  s
-1 mantADP 
k−mD1 0.2 (±0.5) s
-1 mantADP 
 2.611 (±0.003) s
-1 Irreversible mantADP dissociation 
KmD1 0.002 (±0.005)  
k−/k+ mantADP 
kmD2,obs ~0.7 (±0.1) s
-1 mantADP 
KD 0.36 (±0.05) mM mantADP competition 
    
    
RNA-stimulated steady-state ATPase activity 
kcat 0.92 (±0.08) s
-1 NADH linked assay 
    
KM,RNA 3.4 (±0.8) mM NADH linked assay 
    
    
Oxygen Isotope exchange  
Pc 0.0416 (±0.0025)  GCMS 
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Table 2. Rate and equilibrium constants determined from global fitting. 
 
Parameter Value Units Assay 
Steady-state ATPase activity 
kcat 0.04 (±0.0001) s
-1  Eq. 8 
 
   
KM,ATP 1.4 (±1.1)  mM Eq. 9 
  
 
 ATP binding 
k+T  0.92 (±0.03) µM
-1 s-1 KinTek steady-state simulation 
k−T  3670 s
-1 KinTek steady-state simulation 
KT 4 mM Constrained from competition assay 
  
 
 ATP hydrolysis 
k+H 0.16 (±5 × 10
-4) s-1 KinTek steady-state simulation 
 
0.72 (±0.01) s-1 KinTek PiBiP simulation 
k−H 6 × 10
-4 (±8 × 10-7) s-1 KinTek steady-state simulation 
 
0.38 (±0.05) s-1 KinTek PiBiP simulation 
KH 0.004 (±5 × 10
-4) 
 
KinTek steady-state simulation 
 
0.53 (±0.07) 
 
KinTek PiBiP simulation 
  
 
 Phosphate release 
k−Pi 0.062 (Constrained) s
-1 KinTek steady-state simulation 
 
0.04 (±0.02) s-1 KinTek PiBiP simulation 
k+Pi < 1 × 10
-6 (Constrained) s-1 KinTek steady-state simulation 
 
< 1 × 10-6 s-1 KinTek PiBiP simulation 
KPi >1 × 10
-4 µM KinTek steady-state simulation 
 
>1 × 10-4 µM KinTek PiBiP simulation 
  
 
 ADP release 
k+D 0.2 µM
-1 s-1 KinTek steady-state simulation 
k−D 64 (±16) s
-1 KinTek steady-state simulation 
KD 0.31 mM Constrained from competition assay 
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Figure 1  
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Graphical abstract 
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Highlights 
 
 mRNA export from the nucleus requires DEAD-box protein Dbp5/DDX19 ATPase 
activity  
 
 Kinetics and thermodynamics of intrinsic Dbp5 ATPase reveal RNA’s effect on Dbp5 
 
 
 Intrinsic Dbp5 ATPase is limited by slow ATP hydrolysis and slower Pi release  
 
 RNA activates Pi release, but it and RNA binding still limit RNA-stimulated ATPase  
 
 RNA binding and Pi release define RNA-stimulated Dbp5 ATPase for further regulation 
